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Cystic fibrosis is a fatal genetic disorder which afflicts over 50,000 individuals worldwide.  A viable animal model would be invaluable for investigating and combating this fatal disease.  Towards this goal, we have disrupted the mouse cystic fibrosis transmembrane conductance regulator gene in embryonal stem cells using an insertional gene targeting vector, derived germline chimaeras, and studied the offspring of heterozygous crosses.  These homozygous mutant Cftr mice survive beyond weaning.  In vivo electrophysiology demonstrates the predicted defect in chloride ion transport in these mice and, furthermore,  can distinguish between each genotype. In addition, histological analysis detects important hallmarks of human disease pathology.  This insertional mouse mutation provides a valid model system for the development and testing of therapies relevant to the treatment of cystic fibrosis patients.


Cystic fibrosis, an autosomal recessive disorder, is characterised by defective chloride transport in epithelial cells and excess mucus secretion1,2.  Meconium ileus, or neonatal intestinal blockage, is virtually diagnostic of the disease, but is only seen in ~10% of cases1,2.  Pancreatic insufficiency and malabsorption in the gut are common features.  Males are typically infertile due to blockage or absence of the vas deferens1,2,3.  Chronic opportunistic lung infection, probably due to viscid mucus production, is the major cause of premature death1,2.   However, there is a broad spectrum of presentations and variable severity of clinical manifestation1,2; mildly affected patients may have only moderately elevated sweat chloride, minimal lung deficiency and be pancreatic sufficient.  Improved nutritional care, pancreatic enzyme supplementation, aggressive antibiotic treatment and physiotherapy, and earlier diagnosis have all combined to improve dramatically the life expectancy of cystic fibrosis patients.  However, this is still essentially a fatal disease and patients rarely survive beyond the third decade of life.  

Remarkable progress in analysing the biochemical defect in cystic fibrosis has been made following the positional cloning and primary characterisation of the gene4,5,6.   It was named the cystic fibrosis transmembrane conductance regulator (CFTR) in view of its predicted role and from comparison with other gene products of known structure and function5.  Approximately 70% of patients were found to carry a single mutation, F508, a 3bp deletion which removes a single phenylalanine residue6.  Subsequently, over 170 independent CFTR mutations have been identified7.  The F508 mutation is almost invariably associated with severe disease and pancreatic insufficiency8.  However, a small subset of missense mutations are associated with pancreatic sufficiency8.  Homozygous nonsense mutations have been reported both in patients with very mild9,10, or with severe clinical symptoms11,12,  and with or without pancreatic insufficiency.  Missense mutations indicate residues likely to be critical for normal function, a supposition largely borne out by ectopic expression studies13.  

Mutation detection allows accurate prenatal diagnosis in many families, but the majority of new cases of this autosomal recessive disorder arise in the absence of a previous family history.  In most populations, detection rates still fall short of those required for comprehensive screening7.  The aim of experimental research must be to improve diagnosis, disease management and therapy.  Certain limitations of clinical and in vitro studies emphasise the need for an animal model.  It is noteworthy that all but one of sixty missense mutations in man occur at amino acid residues which are conserved in the mouse14.  This argues for a conservation of CFTR function which we test here by a targeted, insertional disruption of the mouse Cftr gene in embryonal stem cells15.  The viability of homozygous mutant offspring together with the pathology and electrophysiology of their epithelial-lined tissues suggests that this mutation creates a mouse which closely models important features of cystic fibrosis in man.


Gene Targeting and Germline Transmission

We have described elsewhere15 the construction of the insertional vector pIV3.5H designed to disrupt the Cftr gene in exon 10.  Briefly, a 3.5kb HindIII fragment of DNA isogenic with the E14 embryonal stem cell line and which encompasses part of intron 9 and extends into exon 10 was cloned into the pMC1neopolyA vector.  This insertional vector was linearised at the unique Asp718 site, electroporated into the E14 embryonal stem cell line, and G418 resistant clones screened by Southern blotting for the presence of a novel, diagnostic fragment using a flanking genomic probe, 1.2H, not present in the vector  (Figure 1a & b).  Correctly targeted clones were obtained at a frequency of about 2% of G418 resistant clones.  Clones retaining a modal chromosome number of 40 and the ability to differentiate in vitro were injected into C57 Bl/6 blastocysts and transferred to pseudopregnant female mice to obtain chimaeric offspring.  Thirteen (ten male) of twentyfour offspring were chimaeric, as judged by coat colour,  and eight males were mated to MF1 (Olac) females to test for germline transmission.  Six males produced offspring of grey coat colour (genotype + / p, c / cch ), indicative of germline transmission.  These were genotyped by Southern blotting using the 1.2H probe.  Approximately half (54 out of 113) were heterozygous for the wild-type 6kb XbaI fragment (wt) and the novel, mutant 5kb XbaI -SalI fragment (m) (Figure 1b).  We designate the insertional mutation as  CftrTgH(neoim)1HGU, but we abbreviate this to cf for simplicity.  The cf / + mice (heterozygous for the insertional mutation) were phenotypically normal.  


Production of Viable Homozygous Mutant ( cf / cf ) Mice

One male (derived from chimaera 42) was mated to three females (all derived from chimaera 48) and produced 24 offspring, of which 8 were wild type ( + / + ), 10 were heterozygous ( + / cf ) and 6 were homozygous mutant ( cf / cf ).  Fig.1b shows an analysis of part of this pedigree.  A single mouse died perinatally, was histologically normal, and genotyped as being cf/+.  All other mice survived beyond weaning and cf/cf mice showed no overt failure to thrive over the study period (up to 30 days post-partum).  


Electrophysiology 

If targeted disruption of the Cftr gene effectively abolishes gene function, we would expect to see electrophysiological changes consistent with the absence of a functional CFTR chloride channel in all cf / cf mice, irrespective of disease status.  A blind trial was carried out on nine mice, comprising one control mouse plus eight offspring selected from the three litters in the study group.  These eight coded mice, and additional mice, were also examined for pathological changes (see below).  Gastrointestinal and respiratory tract potential differences (PDs) were determined in vivo by an established method16, modified for the mouse (E.W.F.W.A., S.N.S., and D.M.G., in preparation).  The pooled results are given in Table 1.  All four cf / cf mice were unequivocally identified.  Baseline rectal PD in the homozygous mutant animals was significantly lower than the combined heterozygous / wild type group.  Colonic / caecal PD was similarly significantly reduced in homozygous mutants. Following perfusion of each of the above regions with a combination of forskolin (an activator of adenylate cyclase) and zardaverine (a phosphodiesterase inhibitor), in the presence of amiloride (an inhibitor of sodium transport), a significant reduction in the resultant hyperpolarization was seen in all homozygous mutant mice.  Nasal PD was significantly increased in the homozygous mutant mice, but no difference was discernible throughout the lower airways below the larynx.  Perfusion of the trachea with a low chloride solution showed a significant reduction in the resultant hyperpolarization in each of the cf / cf animals.  Heterozygotes (range -10 to -11 mV) demonstrated rectal PDs intermediate between cf / cf (range -4 to -9 mV) and + / + (range -18 to -24 mV) mice, as well as either a reduced response to forskolin and zardaverine in the rectum, or to low chloride perfusion in the trachea, neither of which overlapped with the cf / cf values.  In summary, all nine animals were studied without prior knowledge of genotype and all were correctly identified.




Pathology

Histological examination was carried out on formalin fixed tissue from the three litters, described above.  The histology of wild type and heterozygous mice is indistinguishable and completely normal.  Figure 2  shows histologically stained tissue sections of the colon from a) a mutant cf / cf, and b) a heterozygous cf / + mouse, respectively. The mutant cf / cf mouse shows pathological changes consistent with those seen in cystic fibrosis.  There was mild colon dilatation with abnormal mucus accumulation and a resultant distension of epithelial cells, most prominent within the crypts. The gonads were normal, but in one cf / cf male increased mucin was also seen in the vas deferens (Fig. 2 c & d). One mouse, at thirty days post-partum, showed mild focal pulmonary atelectasis (Fig. 2 e & f), consistent with presymptomative lung disease, and mild dilatation of salivary ducts (data not shown).  There was no overt histological abnormality in the pancreas and this is consistent with the average body weight gain of the mice (data not shown). In two out of six cf / cf mice examined, we failed to detect overt histopathological abnormalities, consistent with a variable penetrance, as seen in man.  However, these two mutant mice were readily identified by PD measurements (see above).


Discussion

We have provided evidence that mice homozygous for an insertional disruption of the Cftr gene mimic important features of cystic fibrosis, with altered chloride ion transport in all cases, and variable, but diagnostic pathology in four out of six cf / cf mice examined.    In the large intestine, cystic fibrosis patients demonstrate a reduced rectal PD17, as well as the characteristic physiological defect of impaired chloride secretion, in response to elevation of cAMP18.  We have previously shown in vitro that murine caecum responds to forskolin and zardaverine, in the presence of amiloride, with an increase in PD and equivalent short circuit current, which can be largely inhibited by bumetanide19.  Therefore, this response is very likely to represent chloride secretion.  The large intestines of the four cf / cf mice in this study thus appear to demonstrate two of the electrophysiological abnormalities of the gastrointestinal tract of cystic fibrosis patients.  An elevated nasal PD is recognised as one of the hallmarks of cystic fibrosis16 and is used in the clinical diagnosis of patients.  Human nasal epithelium predominantly absorbs sodium in the resting state and the raised PD in cystic fibrosis relates to an increase in this absorption20.  We have previously shown that murine tracheae display ion transport properties similar to those characteristic of humans19.  Although technical considerations precluded the use of nasal amiloride in this study, the significantly increased nasal PD in the cf / cf mice argues strongly for an increased sodium absorption in the nasal mucosa of these animals.  The lower airway PD of a limited number of cystic fibrosis patients has been shown to be increased16.  Interestingly, this is not consistently observed21,22 and was not seen in this study.  Nevertheless, the tracheae of all the cf / cf animals tested demonstrated the characteristically reduced permeability of these tissues23.  It was of interest that we were able to distinguish heterozygotes on the basis of a minimum of two of the above criteria, although clearly larger numbers of animals need to be studied to confirm these findings.

At this stage, we have no evidence for abnormal pancreatic histology, possibly due to the ameliorating effect of the large volume of acinar fluid seen in the mouse, but not in man (B. Argent, pers. commun.).  Thus, the ductal blockage which typifies most cystic fibrosis patients might be expected to be less severe in mice, or to develop later.  Differences between the pulmonary anatomy of mouse and man has called into question whether a Cftr mutant mouse would mimic the human lung disease7.  However, the one cf / cf mutant mouse described here which exhibited clear signs of lung damage is significant and consistent with the age of onset of lung disease in human patients.  It will be of interest to monitor the effect of aging on lung disease, as well as the consequences of exposure to lung pathogens such as Pseudomonas aeruginosa.  The mucoid form of P. aeruginosa shows a particular association with cystic fibrosis and accelerates lung damage1.  The presence of mucin in the vas deferens of one male examined also mimics the pathology in cystic fibrosis24 and thus this mouse model may be valuable for studying male infertility.  In summary, the mutant cf / cf mice display the well established electrophysiological defect associated with cystic fibrosis and a relatively mild pathology, as judged by histology at the time of examination (10-30 days post-partum).  A long term study of survival and pathology is in progress.   


The age of onset and severity of cystic fibrosis is extremely variable.  At one end of the spectrum, neonates die of meconium ileus, while at the other the disease is not diagnosed until late adolescence, or beyond25.   However, with the exception of pancreatic status, there is as yet no clear correlation between specific mutation and clinical phenotype.  Rather, the weight of evidence favours the existence of additional genetic factors influencing the expression of the disease26.  In this regard, a mouse model has an additional important experimental advantage in that the genetic background can be carefully controlled and modified.  We anticipate that such experiments will clarify the relationship between genotype and phenotype and allow us to address the question of contributory genetic and epigenetic factors.  Ashkenazi Jews12 and Georgian Soviets11 homozygous for 'null' mutations have been reported with severe phenotypes, whereas in populations of mixed ethnic origin comparable mutations were associated with mild disease9,10.  The mice described here, which are the result of outcrossing strain 129 (E14 genotype) to an MF1 outbred genetic background, display a mild phenotype.   Experiments are in progress to determine the phenotypic effect of crossing the insertional mutation onto various inbred backgrounds. 

We chose to adopt an insertional targeting strategy for two practical reasons.  Firstly, previous studies had suggested an increase in ratio of homologous to non-homologous recombination with insertion vs replacement vectors27.  While this appears to be true for Cftr ( 0.05% by replacement28 compared with 2% by insertion15, using overlapping sub-fragments of the same genomic clone of isogenic DNA ), a recent reappraisal questions the validity of the earlier conclusions29.  The second advantage of an insertional strategy is that it can be readily adapted to create specific mutations by the 'hit-and-run' procedure30.  By subtle modification of our insertion vector, we have created an E14 line carrying the most common mutation, F508 (P.D., B.J.S., W.L.K., D.J.P., and J.R.D, in preparation), paving the way for further refinement of the model described here.  An intrinsic property of insertional disruption which may attenuate expected phenotypes merits further comment.  There is an obligate partial duplication of genomic sequences following insertion by homologous recombination, and it is possible for abnormal splicing and exon skipping to produce a normal transcript.  A low level of exon skipping, generating normal transcripts, was detected reported following insertional disruption of the N-myc gene, but nevertheless the mutation generated a distinct lung defect and was perinatally lethal31.  In contrast, no evidence for aberrant splicing was found in cultured ES cells following insertional disruption of the HPRT gene by sensitive criteria29.  In our mice, the ability to distinguish heterozygotes from wild type and mutant mice by rectal potential difference measurements argues that there can only be minimal functional protein. It will be valuable to explore in vivo the pharmacological possibilities for increasing chloride ion channel activity through overstimulation of any residual protein, or via alternative ion channel pathways32.  We are also now in a position to modulate the level of functional CFTR by crossing these mice with other transgenic mice carrying missense mutations.  

In conclusion, the insertional disruption of the mouse Cftr gene produces a phenotype which mirrors several important aspects of the human disorder.  These mutant mice will be valuable in reaching a fuller understanding of the epigenetic and pathophysiological development of the disease.  Future studies will facilitate the development of new procedures, interventions and therapies (including somatic gene therapy) relevant to the management and treatment of cystic fibrosis.
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Table 1:  Potential Difference Measurements in Gastrointestinal and Respiratory Tract.
Gastrointestinal and respiratory tract potential difference (PD) measurements were previously established in a set of MF1 mice (data not shown, results summarised below under Method).  For this experiment, baseline measurements were first confirmed on a normal control mouse.  Eight experimental mice were sampled from three cf / + X cf  / + litters and analysed in a blind trial.  For statistical analysis of significance, the results from individuals identified by DNA analysis as cf / cf were pooled and compared with the combined cf / + and + / + genotypes. Means and (in brackets) standard errors of the means (SEM) are shown, and significant differences between the two classes are asterisked (* = p < 0.05, ** = p < 0.01).  FZ= forskolin plus zardaverine.  An upwards arrow indicates an increase towards more negative values, and conversely for a downwards arrow.

Method:
Buccal PD was used to validate the integrity of the circuit prior to further measurements.  Nasal and airway PDs were recorded following a distal tracheostomy.  Tracheal PD was recorded from the proximal trachea.  'Peripheral airways' represent the most peripheral part of the airways reached by the exploring electrode of 0.5mm diameter.  'Bronchial' measurements were taken at the mid-point between the tracheal and peripheral airway recordings.  Caecal and colonic PD was measured under direct vision following opening of the abdominal cavity.  The composition of the bathing solution (mM) was NaCl, 140; KCl, 6; MgCl2, 1; CaCl2, 2; Glucose, 10; HEPES, 10; pH 7.4 in all experiments except in low chloride solution where NaCl was replaced by equimolar sodium gluconate (measured chloride was 11mM).  The junctional potential between the normal bathing solution and the low chloride solution was ignored because of paired comparisons.  It is unlikely that the paracellular shunt is affected in the tracheal epithelium of cystic fibrosis patients23.  Forskolin (1M) and zardaverine (100M) were dissolved in ethanol and DMSO respectively and were perfused in the presence of amiloride (100M).  The combination of ethanol and DMSO has been shown not to significantly alter murine caecal and tracheal PD19.  The measured murine nasal PD profile mimics that of human nasal epithelium19 and data given are obtained from the maximum measured values.  Comparison of the data was made using  the Mann-Whitney U-test and all values are expressed as the mean SEM, for convenience.  * = p < 0.05, ** = p < 0.01.  Previously recorded nasal PDs measured using the above technique in MF1 mice showed a mean of -15.1 mV (SEM 1.7, n=9) and rectal PDs of -16.7 mV (SEM 1.3, n=7).  For comparison, human nasal PD values are: Mean of normals, -19 mV (range -2 to -36 mV, n=145); mean of cystic fibrosis patients, -46 mV (range -33 to -77 mV, n=60)33.  The murine tracheal PD profile also mimicked that in man16.  Comparable values in unaffected subjects21 are : trachea, -16 mV (SEM 2); bronchial airway, -11 mV (SEM 1), and peripheral airway, -6 mV (SEM 1), n=23.  
Figure legends

FIG. 1 Insertional disruption of the murine Cftr gene.
a, Targeting Scheme. The design of the insertional vector has been described in detail previously15.  The figure illustrates the genomic structure, the point of insertion in intron 9 and the predicted gene disruption.  Probe 1.2H is used to follow insertion events by Southern blot analysis of putative targeted cell lines and derived mice. The diagnostic restriction fragments are indicated.  Abbreviations: S, SalI; H, HindIII, X, XbaI; A, Asp718.
b, Genotype Analysis of Heterozygous cf / + Matings.
Segregation and Southern blot analysis of two of the three sibships described in the study are shown.  Following the proposed rules of the International Standardized Genetic Nomenclature for Mice, we designate the Cftr allele created by the transgene insertion, Cftr TgH(neoim)1HGU.  Male heterozygote A4 (derived from chimaera 42) was crossed with female heterozygotes A12 and A13 (both derived from chimaera 48).  The fourteen offspring were genotyped by Southern blot analysis of tail tip DNA taken at 17 days.  DNAs were digested with XbaI + SalI, transferred to nylon membranes and probed with the 1.2H genomic probe, indicated in Fig. 1a.  The upper hybridising fragment of ~6kb represents the wild type (wt) fragment while the lower hybridising fragment of ~5kb is diagnostic for the insertional mutation (m).  Analysis of the E14 embryonal stem cell line used in the targeting experiment15, together with the targeted Clone 1.6, is shown for comparison.

FIG. 2 Histopathology of cf / cf Mutant Mice.
a, Homozygote cf / cf colon.  Distension of the epithelial cells lining the crypts of colonic mucosa can be seen, caused by mucin accumulation within the cytoplasm.  The glandular architecture is disrupted and the cell nuclei are compressed.  b, Heterozygote, cf / + colon.  The normal colonic mucosa is composed of tubular glands, lined by columnar epithelium.  There is no mucin accumulation or cellular distortion. c, Homozygote cf / cf vas deferens.  The lumen of the vas deferens is occupied by densly eosiniphilic mucin.  d, Heterozygote cf / + vas deferens.  No mucin accumulation has occured.  e, Homozygote cf / cf lung.  There is collapse of the lung parenchyma with mucus obstruction of a small bronchus.  Lesions of this type were focal and most of the lung was morphologically normal.  f, Heterozygote, cf / + lung.  Morphologically normal inflated lung with patent bronchi.

Method:  Tissues were fixed in 10% neutral buffered formalin and subsequently dehydrated through increasing alcohol series, cleared in xylene, and infiltrated with paraffin wax.  Paraffin blocks were sectioned and slides stained with haematoxylin and eosin.



